Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Inflammatory Bowel Diseases

  Free Subscription


24.08.2026

1 Aliment Pharmacol Ther
2 BMC Gastroenterol
1 Clin Gastroenterol Hepatol
1 Clin Res Hepatol Gastroenterol
1 Dig Dis
2 Dig Dis Sci
1 Gastroenterol Hepatol
2 Gastroenterology
6 Inflamm Bowel Dis
3 J Crohns Colitis
1 J Gastroenterol
1 PLoS One


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Aliment Pharmacol Ther

  1. TRUNIGER S, Waber D, Dutschler J, Konig M, et al
    Anti-Integrin alphavbeta6 Autoantibodies Distinguish Ulcerative Colitis From Crohn's Disease With High Diagnostic Accuracy and Outperform ANCA and ASCA Status: A Prospective Cross-Sectional Study.
    Aliment Pharmacol Ther. 2026 Aug 20. doi: 10.1111/apt.70926.
    PubMed         Abstract available


    BMC Gastroenterol

  2. CHUAI Q, Jiang X, Li K, Liu X, et al
    Identification of IL1RN, MUC1, and SERPINA1 as key NET-related biomarkers in ulcerative colitis-associated intestinal fibrosis via bioinformatics and experimental validation.
    BMC Gastroenterol. 2026;26:513.
    PubMed         Abstract available

  3. GERBIER E, Abolhassani N, Dupuis M, Oppliger B, et al
    Use of medications to treat inflammatory bowel diseases before and during pregnancy in Switzerland between 2012 and 2019: an observational study using the claims-based MAMA cohort.
    BMC Gastroenterol. 2026;26:511.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  4. PATEL PV, Moses J, Ali S, Suskind DL, et al
    Aminosalicylate use Increases Corticosteroid Exposure and Decreases Biologic Durability in Pediatric Crohn's Disease.
    Clin Gastroenterol Hepatol. 2026 Aug 21:S1542-3565(26)00630.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  5. NIKAM PP
    Beyond Risk Stratification: Can the Crohn's Disease Clinical Decision Support Tool Truly Guide Resource Allocation?
    Clin Res Hepatol Gastroenterol. 2026 Aug 18:102907.
    PubMed        


    Dig Dis

  6. KHASAWNEH O, Gerges KM, Khasawneh I, Savarino EV, et al
    Using GLP-1 Receptor Agonists in Patients with Inflammatory Bowel Disease: A Systematic Review and Single-Arm Meta-Analysis.
    Dig Dis. 2026 Aug 18:1-24. doi: 10.1159/000553479.
    PubMed         Abstract available


    Dig Dis Sci

  7. HUSAIN KH, Khan H, Thakkar B, Bungish M, et al
    Chronotherapy in Inflammatory Bowel Disease: Biological Rationale, Human Evidence, and a Clinical Implementation Framework.
    Dig Dis Sci. 2026 Aug 18. doi: 10.1007/s10620-026-10196.
    PubMed         Abstract available

  8. LETO AC, Shen M, Aberra FN
    Homemade Microbrew: Auto-brewery Syndrome in a Patient with Crohn's Disease.
    Dig Dis Sci. 2026 Aug 19. doi: 10.1007/s10620-026-10175.
    PubMed        


    Gastroenterol Hepatol

  9. LOZANO OM, Camunas AF, Tercero MA, Ramos MJC, et al
    Accuracy of the vedolizumab Clinical Decision Support Tool in Crohn's disease and its association with long-term persistence: A retrospective cohort study.
    Gastroenterol Hepatol. 2026 Aug 18:502842. doi: 10.1016/j.gastrohep.2026.502842.
    PubMed         Abstract available


    Gastroenterology

  10. BUCK A, Writz C, Umbach M, Widemann K, et al
    WISP1 Drives Intestinal Fibrosis in Crohn's Disease via Metabolic and Rho/ROCK/MRTF-mediated cytoskeletal Remodeling.
    Gastroenterology. 2026 Aug 18:S0016-5085(26)07150.
    PubMed         Abstract available

  11. NOBLE A, Antunes C, Ramsteijn AS, Li X, et al
    Specific epigenetic alterations precede the diagnosis of Inflammatory Bowel Disease in adults in Northern Europe: nationwide analysis in Generation Scotland.
    Gastroenterology. 2026 Aug 17:S0016-5085(26)07159.
    PubMed        


    Inflamm Bowel Dis

  12. ALQINAI B, Gayam S, Hadam-Veverka J
    GLP-1 receptor agonist therapy is associated with increased symptomatic remission in ulcerative colitis: a matched cohort study.
    Inflamm Bowel Dis. 2026 Aug 21:izag167. doi: 10.1093.
    PubMed         Abstract available

  13. BEN-DAVID-NAIM M, Bijaoui D, Iluz N, Adams J, et al
    Modulating immune toxicity in ulcerative colitis using a small molecule RAB27A inhibitor.
    Inflamm Bowel Dis. 2026 Aug 21:izag170. doi: 10.1093.
    PubMed         Abstract available

  14. LIU Z, Wu X, Huang W, He J, et al
    Novel proteomic signatures of stricturing Crohn disease using a treatment-naive cohort.
    Inflamm Bowel Dis. 2026 Aug 20:izag160. doi: 10.1093.
    PubMed         Abstract available

  15. JAMAL F, Gonzalez AJ, Thomas G, Viggiano T, et al
    Coccidioidomycosis in patients with inflammatory bowel disease receiving advanced therapy: An observational study from an endemic tertiary center.
    Inflamm Bowel Dis. 2026 Aug 19:izag168. doi: 10.1093.
    PubMed         Abstract available

  16. GROS B, Frutos C, Brunet E, Valentin-Aragon L, et al
    Hormonal contraception is not associated with recurrent flares in ulcerative colitis: a longitudinal time-dependent analysis.
    Inflamm Bowel Dis. 2026 Aug 18:izag163. doi: 10.1093.
    PubMed         Abstract available

  17. LIN SH, Kuo CJ, Chuang CH, Chang CW, et al
    Effectiveness, Durability, and Safety of Ustekinumab in Inflammatory Bowel Disease: Results from the Taiwan Multicenter Real-world Ustekinumab Study (T-RUST Study).
    Inflamm Bowel Dis. 2026 Aug 18:izag150. doi: 10.1093.
    PubMed         Abstract available


    J Crohns Colitis

  18. SHOUVAL DS, Hojsak I, Miele E, Sokollik C, et al
    Management of pediatric Crohn's disease: an ECCO-ESPGHAN guideline update.
    J Crohns Colitis. 2026;20:jjag084.
    PubMed         Abstract available

  19. HAMMOUDA K, Dakarapu R, Rajendra C, Lee H, et al
    Automated AI-based Mayo Endoscopic Scoring for ulcerative colitis across adult and pediatric cohorts from diverse populations.
    J Crohns Colitis. 2026;20:jjag122.
    PubMed         Abstract available

  20. MARTINS M, Nunes MV, Macedo G, Pioche M, et al
    Efficacy, safety, and outcomes of endoscopic submucosal dissection for inflammatory bowel disease-associated colorectal neoplasia: a systematic review and meta-analysis comparing Asian and Western outcomes.
    J Crohns Colitis. 2026;20:jjag082.
    PubMed         Abstract available


    J Gastroenterol

  21. YIN Y, Wang X, Ou D, Zhou Z, et al
    Multimodal MRI reveals glymphatic system activity associated with systemic inflammation and neuropsychiatric symptoms in Crohn's disease.
    J Gastroenterol. 2026 Aug 16. doi: 10.1007/s00535-026-02505.
    PubMed         Abstract available


    PLoS One

  22. MUSHTAQ S, Saeed S, Khan A, Akhtar TS, et al
    Association between Ulcerative Colitis, mental health, and Quality of Life in a Pakistani cohort: A cross-sectional analysis.
    PLoS One. 2026;21:e0356531.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum